A small-molecule screening strategy to identify suppressors of statin myopathy

The reduction of plasma low-density lipoprotein levels by HMG-CoA reductase inhibitors, or statins, has had a revolutionary impact in medicine, but muscle-related side effects remain a dose-limiting toxicity in many patients. We describe a chemical epistasis approach that can be useful in refining t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Wagner, Bridget K., Gilbert, Tamara J., Hanai, Jun-ichi, Imamura, Shintaro, Bodycombe, Nicole E., Bon, Robin S., Waldmann, Herbert, Clemons, Paul A., Sukhatme, Vikas P., Mootha, Vamsi K.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3176973/
https://ncbi.nlm.nih.gov/pubmed/21732624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cb200206w
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items